EW
Edwards Lifesciences
$83.04
+$0.41 (+0.5%)Jul 27, 2026
Key metrics
The numbers that frame EW today
- Market cap
- $47.81B
- P/E (TTM)
- 43.6
- EV / FCF
- 42.3
- Gross margin
- 77.9%
- EV / Sales
- 7.3
- ROIC
- 19.7%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $72.30
- 52wk High
- $96.29
Growth
Revenue and earnings trend for EW
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about EW
Is Edwards Lifesciences a good buy?
Yes. Edwards Lifesciences has excellent quality and strong momentum. Both signals support the setup. Growth looks mixed. The support signal is useful, but not decisive. We think Edwards Lifesciences is selling at a fair price.
What is the market capitalization of EW?
Edwards Lifesciences's market capitalization is $47.81B.
What is the P/E ratio for EW stock?
Edwards Lifesciences's current P/E ratio is 43.6.
What is the 52-week high for EW stock?
The 52-week high for Edwards Lifesciences is $96.29. The current close of $83.04 is 13.8% below that high.
What is the 52-week low for EW stock?
The 52-week low for Edwards Lifesciences is $72.30. The current close of $83.04 is 14.9% above that low.
Does EW stock pay dividends?
Edwards Lifesciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for EW?
Edwards Lifesciences's Debt / Equity ratio is 0.07.